Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DR26F93G7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,325
Award facts
- Contract value 100% obligated
- $2,324.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,324.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) CF pen 40 mg/0.4 mL on November 14, 2025, with completion targeted for November 17, 2025. This is an unset-aside, competitively awarded contract with place of performance in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply procurement across the federal defense healthcare system.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, holds a significant portfolio of federal medical supply contracts predominantly with the Defense Logistics Agency and its Medical Supply Chain. The company's DLA IDC enables it to supply a comprehensive range of pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including services to the Defense Health Agency and U.S. Coast Guard. This specific delivery order for HUMIRA, a critical biologic medication for autoimmune conditions, represents one of numerous transactions executed under this expansive prime vendor agreement that supports federal medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F93G7?
SPE2DR26F93G7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26F93G7 worth?
The government has obligated $2,325 on SPE2DR26F93G7.
Is contract SPE2DR26F93G7 an order under another contract?
Yes. SPE2DR26F93G7 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F93G7 competed?
The extent of competition for SPE2DR26F93G7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award